Subscribe
Facebook Twitter Instagram Youtube

Viral Hepatitis Foundation Bangladesh

Email

hbd@dhaka.net

Phone

T: +880 2 8821989

Web

www.vhfb.org

Address

House # 109, Road # 4, Block # B Banani Banani Dhaka-1213 Bangladesh
About Viral Hepatitis Foundation Bangladesh

The Viral Hepatitis Foundation Bangladesh is a non-profitable, non-political, non-government, charitable and voluntary foundation.

OBJECTIVES OF THE FOUNDATION

  • To create mass awareness about viral hepatitis
  • To prevent viral hepatitis and provide treatment to liver disease patients at affordable cost
  • To facilitate coalition activities among members by circulating information on research through scientific conferences and workshops.
  • To undertake and carry on any humanitarian or charitflle program for the poor and under privileged people for quality living.
  • To take up programs for promotion of science and education and publish journals, estalish libraries and study centers.
  • To take up programs for distribution of relief among the neglected and at times of natural calamities.
  • To arrange training activities for rural medical practitioners and health workers.
  • To create awareness among the general public regarding the beneficial programs of the Foundation.
  • The Foundation shall be a non-partisan organization and may not be for the benefit of any particular religion, community or caste.
  • To provide expertise/technical assistance to other organizations regarding the above issues.
  • To raise funds and receives donation assistance in order to support the activities of the Foundation.

Sign up to receive updates from WHA

Name(Required)
I would like to hear about(Required)
Confirm consent(Required)

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Hepatitis and PWID/harm reduction 

 

11:35 – 11:40  

Chair: WHO – Intro and set the scene.  

 

11:40 – 11:55  

Co-chair:  EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe. 

 

11:55 – 12:00 

ID 29: Ema Pos (not yet registered) 

Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation. 

 

12:05 – 12:10  

ID 152: Brian Conway (Registered in person) 

Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.

 

12:10 – 12:15 

ID 212: Jasmine West (not yet registered) 

Title: From lived experience to lived expertise: a syndemic approach. 

 

12:15 – 12:20 

ID: 299 Mercy Nyakowa (Registered in person) 

Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya 

 

12:20 – 12:25 

ID: 133 Nalinikanta Rajkumar (Registered in person) 

Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?  

 

12:25 – 12:30 

Q&A and closing remarks   

tHIS

 

IS 

 

BEN’S

 

 

 

BIG 

 

 

TEST

effective case finding strategies

Supported by Vir Biotechnology, Inc

During this session you will hear from hepatitis Delta expert, Dr. Maria Buti, and a patient who has lived with hepatitis Delta in a panel discussion moderated by Dr. Carey Hwang, Chief Medical Officer (interim) of Vir Biotechnology. This panel will inform perspectives on patient needs, opportunities for enhanced screening, and strengthening linkages to care.

Session Agenda

14:40 – 14:45    

Panel overview and introductions facilitated by Dr Carey Hwang (Vir Biotechnology)

14:45 – 15:05   

Panel discussion: Dr Maria Buti (University Hospital Vall d’Hebron, Spain), Milanka Barbosa, Dr Carey Hwang (Chief Medical Officer interim), Vir Biotechnology

15:05 – 15:10    

Final remarks and close